Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bio-Gene Technology Ltd. ( (AU:BGT) ) has shared an update.
Bio-Gene Technology Limited has announced a change in the director’s interest, with Timothy Grogan acquiring 217,392 ordinary shares and 217,392 unlisted options through a placement approved by shareholders. This change reflects the company’s ongoing efforts to engage stakeholders and strengthen its financial position, potentially impacting its market strategy and investor confidence.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited operates in the biotechnology industry, focusing on the development and commercialization of novel insecticides. The company aims to provide solutions that address resistance issues in pest management across various sectors, including agriculture and public health.
Average Trading Volume: 249,678
Technical Sentiment Signal: Sell
Current Market Cap: A$4.8M
Find detailed analytics on BGT stock on TipRanks’ Stock Analysis page.